Polycystic Kidney Disease

CPDTime.
10m

Published: 17 May 2022

Polycystic kidney disease is a chronic, incurable illness estimated to affect between 1 in 500 and 1,000 people (Garvan Institute 2021; Better Health Channel 2017).

What is Polycystic Kidney Disease?

Polycystic kidney disease (PKD) is a predominantly genetic condition causing cysts (fluid-filled blisters) to grow on the kidneys (Better Health Channel 2017).

These cysts gradually enlarge the kidneys as they grow, causing healthy kidney tissue to be compressed. Eventually, this impairs kidney function and in some cases, leads to kidney failure (Better Health Channel 2017; Kidney Health Australia 2019).

Both kidneys are affected, but one might progress earlier than the other (Kidney Health Australia 2019).

As well as in the kidneys, cysts may also grow in other organs, including the liver, pancreas, spleen, ovaries, large bowel, heart and brain (NKF 2018).

polycystic kidney disease
Image credit to CDC/Dr. Edwin P. Ewing, Jr.

What Causes Polycystic Kidney Disease?

PKD occurs due to a mutation in the PKD1, PKD2 or PKHD1 gene (Better Health Channel 2017).

This mutation is believed to cause increased cell growth, which leads to the formation of cysts (Bennett et al. 2020).

In 90% of cases, the mutation is inherited, however, it’s also possible for PKD to occur in someone with no family history of the illness. This is thought to be caused by a spontaneous gene mutation or a different inheritance pattern (Garvan Institute 2021; Better Health Channel 2017).

There are two inheritance patterns of PKD:

  1. Autosomal dominant (ADPKD)
  2. Autosomal recessive (ARPKD).

(Kidney Health Australia 2019)

Autosomal Dominant PKD

polycystic kidney disease autosomal doinant inheritance pattern
Autosomal dominant inheritance pattern means that only one copy of the mutated gene is needed to cause PKD.

ADPKD is the most common type of PKD (Kidney Health Australia 2019).

In ADPKD, cysts begin to form during childhood but are initially microscopic and impossible to detect until later in life. Symptoms don’t typically develop until between 30 and 40 years of age (Kidney Health Australia 2019).

An autosomal dominant inheritance pattern means that only one copy of the mutated gene is needed to cause PKD. In other words, a child has a 50% chance of inheriting PKD if one of their parents has the mutated gene (Mayo Clinic 2020).

Autosomal Recessive PKD

polycystic kidney disease autosomal recessive inheritance pattern
It's only possible to inherit ARPKD if both parents are carriers of the mutated gene.

ARPKD is much less common. Unlike ARPKD, symptoms typically begin to develop during early childhood, or in some cases, as early as in the womb (Better Health Channel 2017).

ARPKD can cause kidney and/or liver problems later in the patient’s life (Kidney Health Australia 2019).

An autosomal recessive inheritance pattern means that two copies of the mutated gene are needed to cause PKD. In other words, the condition can only be inherited if both parents are carrying the mutated gene and the child inherits one mutated gene from each parent. One mutated gene is not enough to cause PKD alone - instead, the child will become an asymptomatic carrier. The likelihood of inheriting two copies of the mutated gene is 25% (Mayo Clinic 2020).

Symptoms of Polycystic Kidney Disease

Autosomal Dominant PKD

People with ADPKD don’t usually present with symptoms in early life, but between the ages of 30 and 40 (on average), they may begin to experience:

  • Polyuria (needing to urinate more often)
  • Nocturia (needing to urinate during the night)
  • Kidney pain
  • Haematuria (blood in urine)
  • Hypertension
  • Impaired kidney function or kidney failure
  • Enlarged, painful abdomen
  • Urinary tract infections
  • Kidney stones
  • Hernias
  • Cysts in other organs (often the liver)
  • Mitral valve prolapse (caused by cysts in the heart), which may lead to a heart murmur
  • Intracranial aneurysm (caused by cysts in the brain), which can lead to a stroke or even death.

(Kidney Health Australia 2019; NKF 2018)

About 50% of people with ADPKD will experience kidney failure by the age of 60 (Kidney Health Australia 2019).

Autosomal Recessive PKD

Symptoms of ARPKD may include:

  • Unusually-shaped face (due to a lack of fluid surrounding the fetus in the uterus)
  • Delayed or difficult childbirth
  • Hypertension
  • Swollen abdomen caused by enlarged kidneys, liver and spleen
  • Heart or lung defects
  • Kidney failure at birth or in the first few weeks of life
  • Failure to thrive
  • High blood pressure in the liver
  • Haematuria
  • Hypertension
  • Anaemia.

(Kidney Health Australia 2019)

Diagnosis of Polycystic Kidney Disease

polycystic kidney disease diagnosis ultrasound
The most reliable, cost-effective and non-invasive method of detecting cysts is via an ultrasound.

Autosomal recessive PKD can usually be diagnosed early due to patients commonly presenting with severe symptoms at a young age (Kidney Health Australia 2019).

Autosomal dominant PKD, on the other hand, may go unnoticed for many years and is often detected during investigations for other health issues (e.g. urinary tract infection). Some people with ADPKD aren’t diagnosed until their kidneys begin to fail (Better Health Channel 2017).

Diagnosis of PKD will take into consideration the patient’s age, as well as any family history of the condition (Kidney Health Australia 2019).

The most reliable, cost-effective and non-invasive method of detecting cysts is via an ultrasound (NKF 2018).

If cysts are detected, further diagnostic tests might be performed, including:

  • Physical examination to detect hypertension or enlarged kidneys
  • Blood tests to check kidney function
  • Urine tests to assess for haematuria and proteinuria (protein in urine).

(Kidney Health Australia 2019)

In some cases, genetic testing might be used, but it isn’t a routine diagnostic method as it’s costly and isn’t always accurate (NKF 2018).

PKD will be diagnosed in at-risk people with a family history of the condition if:

Patient age Number of cysts found on ultrasound
15-39 years At least 3 (in total)
40-59 years At least 2 in each kidney
< 60 years At least 4 in each kidney

(Kidney Health Australia 2019)

Treatment for Polycystic Kidney Disease

There is no cure for PKD, but early detection and management can help to reduce the risk of complications (Better Health Channel 2017).

Typically, first-line treatment involves slowing the growth of cysts via lifestyle management and modification (e.g. regular exercise, smoking cessation, dietary changes), along with controlling blood pressure. In some cases, these are the only interventions needed (Kidney Health Australia 2019).

Other interventions may include:

  • Antihypertensive medicine to manage hypertension
  • Draining cysts to relieve pain
  • Fluids, analgesia, antibiotics and rest to treat haematuria
  • Antibiotic treatment for any urinary tract infections
  • Medicine (tolvaptan) to slow the progression of cysts (for adults with rapidly progressing ADPKD)
  • Dialysis or a kidney transplant to treat kidney failure
  • Psychological support to help manage feelings of sadness and anxiety associated with a PKD diagnosis
  • Avoiding contact sports if the kidneys, liver, spleen or abdomen are enlarged, as these organs could potentially be injured if hit.

(Kidney Health Australia 2019; Better Health Channel 2017)

Patients should also be advised to avoid taking non-steroidal anti-inflammatory drugs (NSAIDs) as they can potentially worsen kidney function (Better Health Channel 2017).

References


Test Your Knowledge

Question 1 of 3

A couple is planning to have a child. The mother is a carrier of autonomic recessive polycystic kidney disease and the father has two normal genes. What is the likelihood of the child inheriting PKD?

Author

educator profile image
Ausmed View profile
Ausmed’s editorial team is committed to providing high-quality, well-researched and reputable education to our users, free of any commercial bias or conflict of interest. All education produced by Ausmed is developed in consultation with healthcare professionals and undergoes a rigorous review process to ensure the relevancy of all healthcare information and updates to changes in practice. If you have identified an issue with the education offered by Ausmed or wish to submit feedback to Ausmed's editorial team, please email ausmed@ausmed.com.au with your concerns.